Lupin recalls over 16,000 bottles of generic tuberculosis drug in US ...Middle East

Drug maker Lupin is recalling 16,056 bottles of Rifampin Capsules, used in the treatment of all forms of tuberculosis, in the US market due to a manufacturing issue, according to the US Food and Drug Administration. As per the latest Enforcement Report by the US health regulator, Lupin Pharmaceuticals Inc, a US-based arm of the Mumbai-based drug major, is recalling the affected lot due to "Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study." The affected lot has been produced at Lupin's Aurangabad plant and marketed in the US by Baltimore-based Lupin Pharmaceuticals. The company initiated Class II nationwide (US) recal

Hence then, the article about lupin recalls over 16 000 bottles of generic tuberculosis drug in us was published today ( Saturday 21/01/2023 - 12:40 PM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin recalls over 16,000 bottles of generic tuberculosis drug in US )

Also on site :

• New Supermetrics Report Reveals Why Marketing's AI Readiness Still Falls Short
• HCLTech affiche un premier trimestre solide, porté par un volume de commandes record de 2,4 milliards de dollars
• LawProactive Launches SB 37-Compliant Attorney Marketing Software With Exclusive City Territories Across California